- Home
- OBIO vs GF Comparison
OBIO vs GF Comparison
Compare OBIO & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- GF
- Stock Information
- Founded
- OBIO 2017
- GF 1990
- Country
- OBIO United States
- GF Germany
- Employees
- OBIO N/A
- GF N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- GF Investment Managers
- Sector
- OBIO Health Care
- GF Finance
- Exchange
- OBIO Nasdaq
- GF Nasdaq
- Market Cap
- OBIO 151.3M
- GF 155.4M
- IPO Year
- OBIO N/A
- GF N/A
- Fundamental
- Price
- OBIO $2.85
- GF $9.97
- Analyst Decision
- OBIO Strong Buy
- GF
- Analyst Count
- OBIO 5
- GF 0
- Target Price
- OBIO $15.00
- GF N/A
- AVG Volume (30 Days)
- OBIO 69.1K
- GF 28.1K
- Earning Date
- OBIO 05-12-2025
- GF 01-01-0001
- Dividend Yield
- OBIO N/A
- GF 0.82%
- EPS Growth
- OBIO N/A
- GF N/A
- EPS
- OBIO N/A
- GF N/A
- Revenue
- OBIO $2,638,000.00
- GF N/A
- Revenue This Year
- OBIO $27.37
- GF N/A
- Revenue Next Year
- OBIO $42.68
- GF N/A
- P/E Ratio
- OBIO N/A
- GF N/A
- Revenue Growth
- OBIO N/A
- GF N/A
- 52 Week Low
- OBIO $2.49
- GF $7.38
- 52 Week High
- OBIO $8.87
- GF $9.41
- Technical
- Relative Strength Index (RSI)
- OBIO 36.86
- GF 56.31
- Support Level
- OBIO $2.75
- GF $8.80
- Resistance Level
- OBIO $3.26
- GF $9.75
- Average True Range (ATR)
- OBIO 0.48
- GF 0.28
- MACD
- OBIO -0.01
- GF 0.01
- Stochastic Oscillator
- OBIO 16.82
- GF 92.13
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.